SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15737947
Source:
http://linkedlifedata.com/resource/pubmed/id/15737947
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0019693
,
umls-concept:C0031327
,
umls-concept:C0036043
,
umls-concept:C0087111
,
umls-concept:C0205210
,
umls-concept:C0205547
,
umls-concept:C1145759
pubmed:issue
1
pubmed:dateCreated
2005-3-1
pubmed:abstractText
Atazanavir (ATV) is a novel protease inhibitor that has been recently introduced into therapy of HIV infection. Currently there is little data on ATV therapy from daily practice.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9517857
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Protease Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines
,
http://linkedlifedata.com/resource/pubmed/chemical/Ritonavir
,
http://linkedlifedata.com/resource/pubmed/chemical/atazanavir
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0949-2321
pubmed:author
pubmed-author:FeldeGG
,
pubmed-author:GöbelsKK
,
pubmed-author:HäussingerDD
,
pubmed-author:KroidlAA
,
pubmed-author:KuschakDD
,
pubmed-author:LeidelRR
,
pubmed-author:OetteMarkM
,
pubmed-author:SagivEE
pubmed:issnType
Print
pubmed:day
28
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7-10
pubmed:meshHeading
pubmed-meshheading:15737947-Anti-HIV Agents
,
pubmed-meshheading:15737947-Clinical Chemistry Tests
,
pubmed-meshheading:15737947-Drug Monitoring
,
pubmed-meshheading:15737947-Drug Therapy, Combination
,
pubmed-meshheading:15737947-HIV Infections
,
pubmed-meshheading:15737947-HIV Protease Inhibitors
,
pubmed-meshheading:15737947-Hematologic Tests
,
pubmed-meshheading:15737947-Humans
,
pubmed-meshheading:15737947-Middle Aged
,
pubmed-meshheading:15737947-Oligopeptides
,
pubmed-meshheading:15737947-Pyridines
,
pubmed-meshheading:15737947-Retrospective Studies
,
pubmed-meshheading:15737947-Ritonavir
,
pubmed-meshheading:15737947-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Atazanavir for treatment of HIV infection in clinical routine: efficacy, pharmacokinetics and safety.
pubmed:affiliation
Clinic for Gastroenterology, Hepatology, and Infectious Diseases, University Clinic of Düsseldorf, Moorenstr. 5, D-40225 Düsseldorf, Germany.
pubmed:publicationType
Journal Article
,
Clinical Trial